MARLBOROUGH, Mass., May 15, 2023
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will
participate in Bernstein's 39th Annual Strategic
Decisions Conference on Wednesday, May 31,
2023.
Mike Mahoney, chairman and chief
executive officer, will participate in a 50-minute
question-and-answer session with the host analyst at approximately
8:00 a.m. EDT. A live webcast of the
session will be available on the Investor Relations section of the
Boston Scientific website at investors.bostonscientific.com.
The replay of the webcast will be accessible at
investors.bostonscientific.com beginning approximately one
hour following the completion of each event.
About Boston Scientific
Boston Scientific
transforms lives through innovative medical solutions that improve
the health of patients around the world. As a global medical
technology leader for more than 40 years, we advance science for
life by providing a broad range of high performance solutions that
address unmet patient needs and reduce the cost of healthcare. For
more information, visit www.bostonscientific.com and
connect on Twitter and
Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Kate Haranis
|
Lauren
Tengler
|
508-683-6585
(office)
|
508-683-4479
(office)
|
Media Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
Kate.Haranis@bsci.com
|
BSXInvestorRelations@bsci.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-bernsteins-39th-annual-strategic-decisions-conference-301824527.html
SOURCE Boston Scientific Corporation